The gene expression profile analysis in a mouse model of tauopathy (rTg4510) which expresses the P301L mutation, revealed upregulation of pro-inflammatory markers such as complement 4B, glial fibrillary acidic protein (GFAP) and osteopontin (Spp1) on treatment with LPS. Here, GFAP is linked to tauopathy.